Literature DB >> 31687259

A Novel Frameshift Mutation Associated with Hurler's Syndrome: A Case Report.

Mana Kamranjam1, Seyedeh Maryam Hosseini1, Mohammadreza Alaei2.   

Abstract

Mucopolysaccharidosis 1 (MPS1) is a rare inherited lysosomal storage disorder resulting from the absence or reduction of lysosomal alpha-l-iduronidase due to mutations in the IDUA gene. Three major clinical manifestations have been established including Hurler's or severe type (OMIM 607914), Hurler-Scheie or intermediate type (MIM 607914) and Scheie's or attenuated type (MIM 607016). In the present study, a patient whose disease was diagnosed by biochemical and enzymatic assay was studied in our laboratory. Molecular analysis implemented by PCR-sequencing of all 14 exons and exon-intron junctions confirmed a novel deleterious mutation in a homozygous state. The result of this study has broadened the genotypic spectrum of MPS1 patients, assisting in a more effective approach for carrier testing and counseling. © Thieme Medical Publishers.

Entities:  

Keywords:  alpha-l-iduronidase; lysosomal storage disorder; mucopolysaccharidosis type 1; mutation

Year:  2019        PMID: 31687259      PMCID: PMC6824898          DOI: 10.1055/s-0039-1685190

Source DB:  PubMed          Journal:  J Pediatr Genet        ISSN: 2146-460X


  25 in total

1.  Molecular characterization of 355 mucopolysaccharidosis patients reveals 104 novel mutations.

Authors:  Laura M Pollard; Julie R Jones; Tim C Wood
Journal:  J Inherit Metab Dis       Date:  2012-09-14       Impact factor: 4.982

2.  IDUA mutational profiling of a cohort of 102 European patients with mucopolysaccharidosis type I: identification and characterization of 35 novel α-L-iduronidase (IDUA) alleles.

Authors:  Francesca Bertola; Mirella Filocamo; Giorgio Casati; Matthew Mort; Camillo Rosano; Anna Tylki-Szymanska; Beyhan Tüysüz; Orazio Gabrielli; Serena Grossi; Maurizio Scarpa; Giancarlo Parenti; Daniela Antuzzi; Jaime Dalmau; Maja Di Rocco; Carlo Dionisi Vici; Ilyas Okur; Jordi Rosell; Attilio Rovelli; Francesca Furlan; Miriam Rigoldi; Andrea Biondi; David N Cooper; Rossella Parini
Journal:  Hum Mutat       Date:  2011-03-10       Impact factor: 4.878

Review 3.  Nonsense-mediated decay in genetic disease: friend or foe?

Authors:  Jake N Miller; David A Pearce
Journal:  Mutat Res Rev Mutat Res       Date:  2014-05-28       Impact factor: 5.657

Review 4.  Can mucopolysaccharidosis type I disease severity be predicted based on a patient's genotype? A comprehensive review of the literature.

Authors:  Nancy J Terlato; Gerald F Cox
Journal:  Genet Med       Date:  2003 Jul-Aug       Impact factor: 8.822

5.  Childhood onset of Scheie syndrome, the attenuated form of mucopolysaccharidosis I.

Authors:  Janet A Thomas; Michael Beck; Joe T R Clarke; Gerald F Cox
Journal:  J Inherit Metab Dis       Date:  2010-06-02       Impact factor: 4.982

Review 6.  Molecular genetics of mucopolysaccharidosis type I: diagnostic, clinical, and biological implications.

Authors:  H S Scott; S Bunge; A Gal; L A Clarke; C P Morris; J J Hopwood
Journal:  Hum Mutat       Date:  1995       Impact factor: 4.878

7.  Residual α-L-iduronidase activity in fibroblasts of mild to severe Mucopolysaccharidosis type I patients.

Authors:  Esmee Oussoren; Joke Keulemans; Otto P van Diggelen; Linda F Oemardien; Remco G Timmermans; Ans T van der Ploeg; George J G Ruijter
Journal:  Mol Genet Metab       Date:  2013-06-04       Impact factor: 4.797

8.  Enzyme replacement therapy and/or hematopoietic stem cell transplantation at diagnosis in patients with mucopolysaccharidosis type I: results of a European consensus procedure.

Authors:  Minke H de Ru; Jaap J Boelens; Anibh M Das; Simon A Jones; Johanna H van der Lee; Nizar Mahlaoui; Eugen Mengel; Martin Offringa; Anne O'Meara; Rossella Parini; Attilio Rovelli; Karl-Walter Sykora; Vassili Valayannopoulos; Ashok Vellodi; Robert F Wynn; Frits A Wijburg
Journal:  Orphanet J Rare Dis       Date:  2011-08-10       Impact factor: 4.123

9.  Insights into mucopolysaccharidosis I from the structure and action of α-L-iduronidase.

Authors:  Haiying Bie; Jiang Yin; Xu He; Allison R Kermode; Ethan D Goddard-Borger; Stephen G Withers; Michael N G James
Journal:  Nat Chem Biol       Date:  2013-09-11       Impact factor: 15.040

10.  Mucopolysaccharidosis type I in 21 Czech and Slovak patients: mutation analysis suggests a functional importance of C-terminus of the IDUA protein.

Authors:  Alzbeta Vazna; Clare Beesley; Linda Berna; Larisa Stolnaja; Helena Myskova; Michaela Bouckova; Hana Vlaskova; Helena Poupetova; Jiri Zeman; Martin Magner; Anna Hlavata; Bryan Winchester; Martin Hrebicek; Lenka Dvorakova
Journal:  Am J Med Genet A       Date:  2009-05       Impact factor: 2.802

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.